CISPLATIN/PACLITAXEL VS CISPLATIN/TENIPOSIDE FOR ADVANCED NON-SMALL-CELL LUNG CANCER

Giuseppe Giaccone,Pieter E. Postmus,Ted A. W. Splinter,Maria Diaz-Puente,Nico van Zandwijk,Giorgio V. Scagliotti,Andrea Ardizzoni,Jan P. van Meerbeeck,C Debruyne,Tarek Sahmoud

CISPLATIN/PACLITAXEL VS CISPLATIN/TENIPOSIDE FOR ADVANCED NON-SMALL-CELL LUNG CANCER

1997

Giuseppe Giaccone
Pieter E. Postmus
Ted A. W. Splinter
Maria Diaz-Puente
Nico van Zandwijk
Giorgio V. Scagliotti
Andrea Ardizzoni
Jan P. van Meerbeeck
C Debruyne
Tarek Sahmoud

A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative

Keywords:

Pathology
Cisplatin/Teniposide
Cell
Medicine
Lung cancer
Cancer research
Cisplatin/paclitaxel
Cancer
Ovarian cancer
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations